The grants will enable CDC to work in collaboration with partners to advance the implementation of meningitis and rotavirus vaccines, ensuring global disease protection.

To ensure impact and effectiveness of rotavirus vaccines and sustain vaccine use by policy makers, physicians and parents to increase the speed of adoption of vaccine by other countries in Africa and around the world.

To support the production and qualification of inactivated rotavirus vaccine clinical material.

To help implement the CDC Foundation programs and activities supporting the Targeted Country Assistance portion of the 2022-2025 Partners’ Engagement Framework.

To support the chemistry, manufacturing and control (CMC) and preclinical development of an inactivated rotavirus vaccine.

To provide travel support for onsite technical assistance to countries conducting various rotavirus studies.

To show the health impact of low-cost, Indian-made rotavirus vaccines in high burden, low-income countries of Africa and Asia.

To leverage the WHO Global Rotavirus Surveillance Network (GRSN) by using novel technology to achieve a better understanding of the role of enteric pathogens other than rotavirus in childhood diarrhea requiring hospitalization and create the Global Pediatric Diarrheal Surveillance Network (GPDS).